Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cefotaxime in pneumococcal meningitis.

H Lecour, A Seara, A M Miranda

    Infection
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Unilateral biportal endoscopy versus anterior cervical discectomy and fusion for cervical radiculopathy: a meta-analysis.

    Acta orthopaedica Belgica·2026
    Same author

    Soil hydromorphy and aluminum saturation shape tree community composition in a riparian ecotone, Paraná, Brazil.

    Brazilian journal of biology = Revista brasleira de biologia·2025
    Same author

    Understanding the Environmental Impact of a Mine Dam Rupture in Brazil: Prospects for Remediation.

    Journal of environmental quality·2019
    Same author

    Rapid mask prototyping for microfluidics.

    Biomicrofluidics·2016
    Same author

    Dietary intake and food contributors of polyphenols in adults and elderly adults of Sao Paulo: a population-based study.

    The British journal of nutrition·2016
    Same author

    High intake of heterocyclic amines from meat is associated with oxidative stress.

    The British journal of nutrition·2015

    Cefotaxime (CTX) effectively treats pneumococcal meningitis in patients of all ages. This safe and successful therapy achieved high cure rates and rapid cerebrospinal fluid sterilization.

    Area of Science:

    • Infectious Diseases
    • Neurology
    • Pharmacology

    Background:

    • Pneumococcal meningitis remains a significant cause of morbidity and mortality.
    • Effective antibiotic therapy is crucial for improving patient outcomes.

    Purpose of the Study:

    • To evaluate the efficacy and safety of cefotaxime (CTX) as a single-drug therapy for pneumococcal meningitis.

    Main Methods:

    • A cohort of 46 patients with pneumococcal meningitis received cefotaxime (CTX) treatment.
    • Dosage and duration of CTX therapy were standardized.
    • Cerebrospinal fluid (CSF) sterilization and clinical outcomes were monitored.

    Main Results:

    • All bacterial isolates were sensitive to cefotaxime (CTX).

    Related Experiment Videos

  • A high cure rate of 87.0% was achieved.
  • Rapid CSF sterilization occurred within 72 hours in most patients.
  • The overall mortality rate was 13.0%, with higher rates in comatose patients.

    • Conclusions:

    • Cefotaxime (CTX) is a safe and highly effective treatment for pneumococcal meningitis.
    • Early treatment initiation and appropriate dosage contribute to successful outcomes.
    • CTX demonstrates excellent penetration into the CSF, facilitating pathogen eradication.